Copyright
©The Author(s) 2021.
World J Crit Care Med. Sep 9, 2021; 10(5): 290-300
Published online Sep 9, 2021. doi: 10.5492/wjccm.v10.i5.290
Published online Sep 9, 2021. doi: 10.5492/wjccm.v10.i5.290
Ref. | Age, yr | Study design, country/territory, enrollment period | Sample size (exposure/control) | Location | Shockable initial rhythm (exposure/control), % | Witnessed arrest (exposure/control), % | Bystander CPR (exposure/control), % | Intervention | Comparator | Outcomes of interest |
Bolvardi et al[17], 2016 | 68.9 ± 16.0 | RCT, Iran, 2015 | 50 (25/25) | OHCA | 28 (20/36) | N/A | N/A | 1 mg epinephrine plus 125 mg methylpredni-solone during the first cycle of resuscitation | 1 mg epinephrine plus saline during the first cycle of resuscitation | Successful resuscitation; Survival to hospital discharge; Neurological outcomes at hospital discharge |
Mentzelopoulos et al[9], 2009 | 67.4 | RCT, Greece, Jul 2006 to Mar 2007 | 100 (48/52) | IHCA | 14 (15/13) | 81 (79/83) | N/A | 1 IU vasopressin plus 1 mg epinephrine for the first 5 CPR cycles and 40 mg methylprednisolone. Shock after resuscitation was treated with stress-dose hydrocortisone (300 mg daily for 7 d with gradual tapering) | Placebo (saline) plus 1 mg epinephrine for the first 5 CPR cycles. Shock after resuscitation was treated with saline placebo | Sustained ROSC; Survival to hospital discharge |
Mentzelopoulos et al[7], 2013 | 63.0 | RCT, Greece, Sep 2008 to Oct 2010 | 268 (130/138) | IHCA | 16.8 (16.7/16.9) | 92.2 (91.3/93/1) | N/A | 1 IU vasopressin plus 1 mg epinephrine for the first 5 CPR cycles and 40 mg methylprednisolone. Shock after resuscitation was treated with stress-dose hydrocortisone (300 mg daily for 7 d with gradual tapering) | Placebo (saline) plus 1 mg epinephrine for the first 5 CPR cycles. Shock after resuscitation was treated with saline placebo | ROSC ≥ 20 min; Survival to hospital discharge; Neurological outcomes at hospital discharge |
Paris et al[10], 1984 | N/A | RCT, United States, Mar 1982 to Jan 1983 | 83 (37/46) | OHCA | 48.2 (41.3/56.8) | N/A | 30.1 (36.9/21.6) | 100 mg dexamethasone | The same volume of saline | Survival to hospital admission; Survival to hospital discharge |
Tsai et al[11], 2007 | 72.5 ± 16.2 | Prospective non-RCT, Taiwan, Oct 2004 to Jul 2005 | 97 (36/61) | Non-trauma, OHCA | 10.3 (11/10) | 75.3 (83/71) | N/A | 100 mg hydrocortisone | Saline as placebo | Sustained ROSC; Survival to hospital discharge |
Tsai et al[18], 2016 | 68.2 | Retrospective, Taiwan, 2004-2011 | 145644 (2912/142732) | IHCA (at the ED) | 20.6 (33.4/20.3) | N/A | N/A | Any forms of steroid use | No steroid use | Survival to hospital admission; Survival to hospital discharge; 1-yr survival |
- Citation: Wongtanasarasin W, Krintratun S. Clinical benefits of corticosteroid administration during adult cardiopulmonary resuscitation: A systemic review and meta-analysis. World J Crit Care Med 2021; 10(5): 290-300
- URL: https://www.wjgnet.com/2220-3141/full/v10/i5/290.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v10.i5.290